Author information

• ¹Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia.
• ²Department of Medicine, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia.
• ³Department of Biostatistics, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia.
• ⁴Division of Gastroenterology, Hepatology and Nutrition, Virginia Commonwealth University and Richmond VA Medical Center, Richmond, Virginia. Electronic address: jasmohan.bajaj@vcuhealth.org.

Abstract

Cirrhosis-related neurocognitive impairment caused by covert or minimal hepatic encephalopathy (CHE) affects psychosocial function, increases risk of overt hepatic encephalopathy (OHE) development, and worsens survival.^1,2 However, detection in clinical practice is challenging.² One modality used for screening and prediction of outcomes related to cirrhosis is the EncephalApp Stroop, but it can require up to 10 minutes. Furthermore, the assessment comprises of distinct stages of difficulty, with an easier "Off" stage and a more challenging "On" stage.³ To alleviate these concerns, QuickStroop, which takes <1 minute, was developed. This uses only the first 2 runs of the Off stage of the EncephalApp Stroop, where number signs presented in red, green, or blue need to be matched quickly to their respective colors.⁴ A prior study showed these versions were comparable cross-sectionally to diagnose CHE.⁴ However, the utility of QuickStroop to predict cirrhosis-related outcomes is unclear.^5-7 Our aim was to determine the ability of QuickStroop to determine time to development of OHE and OHE-related hospitalizations, all-cause hospitalizations, and death in outpatients with cirrhosis.